2 weeks Ago By Defense World Staff
Franklin Resources Inc. reduced its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 3.
6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,563 shares of the company’s stock after selling 761 shares during the period. Franklin Resources Inc.
’s holdings in Surgery Partners were worth $435,000 at the end of the most recent reporting period. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Principal Financial Group Inc.
bought a new stake in shares of Surgery Partners during the 3rd quarter worth $1,469,000. Geode Capital Management LLC boosted its stake in shares of Surgery Partners by 2.4% in the 3rd quarter.
Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after purchasing an additional 42,897 shares in the last quarter. AlphaCentric Advisors LLC bought a new stake in shares of Surgery Partners during the 4th quarter valued at approximately $374,000. JPMorgan Chase & Co.
increased its position in Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co.
now owns 189,436 shares of the company’s stock worth $6,107,000 after purchasing an additional 5,551 shares in the last quarter. Finally, Norges Bank bought a new position in Surgery Partners in the 4th quarter valued at approximately $15,796,000. Surgery Partners Trading Up 0.
6 %Shares of SGRY stock opened at $21.22 on Friday. Surgery Partners, Inc.
has a 1-year low of $19.50 and a 1-year high of $33.97.
The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.
99. The stock has a market cap of $2.71 billion, a price-to-earnings ratio of -44.
21, a PEG ratio of 19.21 and a beta of 2.40.
The stock has a 50-day moving average of $23.63 and a 200-day moving average of $24.51.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last announced its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.
38 by $0.01. Surgery Partners had a positive return on equity of 2.
85% and a negative net margin of 2.03%. The business had revenue of $864.
40 million for the quarter, compared to analysts’ expectations of $828.09 million. On average, equities research analysts forecast that Surgery Partners, Inc.
will post 0.67 earnings per share for the current year. Wall Street Analysts Forecast GrowthA number of brokerages have recently commented on SGRY.
Royal Bank of Canada reiterated an “outperform” rating and issued a $35.00 price target on shares of Surgery Partners in a research note on Tuesday, March 25th. Macquarie cut their price target on Surgery Partners from $34.
00 to $33.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock.
Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $36.63.View Our Latest Report on SGRYInsider Transactions at Surgery PartnersIn other Surgery Partners news, insider Harrison R.
Bane sold 56,315 shares of Surgery Partners stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.64, for a total value of $1,443,916.
60. Following the completion of the sale, the insider now directly owns 107,037 shares in the company, valued at approximately $2,744,428.68.
The trade was a 34.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Also, insider Marissa Brittenham sold 3,156 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.
04. Following the completion of the transaction, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72.
This trade represents a 4.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here.
Insiders sold a total of 106,622 shares of company stock worth $2,717,860 over the last three months. 2.30% of the stock is owned by company insiders.
Surgery Partners Profile (Free Report)Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.See AlsoFive stocks we like better than Surgery PartnersDividend Screener: How to Evaluate Dividend Stocks Before BuyingTariff Exemptions Set the Stage for a Taiwan Semiconductor RallyHigh Dividend REITs: Are They an Ideal Way to Diversify?Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.
S. DollarWhat is a Stock Market Index and How Do You Use Them?Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk.
